Case File
efta-01760929DOJ Data Set 10OtherEFTA01760929
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01760929
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
S A
Sent:
Sunday, February 24, 2013 3:58 PM
To:
Jeffrey epstein usa
Subject:
Fwd: RE:
Sent from my iPad
MP
Begin forwarded message:
From: Hani Salah Mal
Date: February 24, 2013, 16:12:41 GMT+03:00
To: SA
Subject: RE:
Dear Chairman,
I spoke to Ian about this and his reply was a little hazy in that he said that:
1. This would not be applicable in our case as they know where FAH is anyway and this is usually in case where
the suspect has disappeared or has eloped to a third country; and that
2. Even if could be the and we lose the case, then what other option do we have.
3. He recommends we stick to our current strategy of Yemen and only Yemen.
Best regards,
Hani Salah
From: S A imailto
Sent: 22 February 2013 21:58
To: Hani Salah
EFTA_R1_00065373
EFTA01760929
Subject: Fwd:
What does it says
Sent from my iPad
Begin forwarded message:
From: Jeffrey Epstein <[email protected] <mailto:[email protected]»
Date: February 21, 2013, 14:30:53 GMT+03:00
To: S A <
this would allow afull defense with little risk http://www.stl-tsl.org/en/about-the-stl/unique-
features/trials-i n-absentia-are-al lowed chttp://www.stl-tsl.org/en/a bout-the-stl/unique-features/trials-in-absentia-are-
allowed>
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email and any attachment are confidential and intended solely for the use of the individual or entity to
whom they are addressed. If you are not the intended recipient, or an employee or agent responsible for delivering this
message to the intended recipient, any disclosure, copying, distribution or use of its content is strictly prohibited, and
you should immediately notify the sender and then delete it and any attachments from your system.
WARNING. Computer Viruses can be transmitted via email. The recipient should check this email and any
attachments for the presence of viruses. Although we have taken reasonable precautions to ensure that no viruses are
present in this email, we cannot accept responsibility for any loss or damage arising from the use of this email or
attachments.
2
EFTA_R1_00065374
EFTA01760930
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.stl-tsl.org/en/about-the-stl/uniqueRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.